These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23131690)

  • 41. Practical management problems of stable chronic obstructive pulmonary disease in the elderly.
    Pistelli R; Ferrara L; Misuraca C; Bustacchini S
    Curr Opin Pulm Med; 2011 Dec; 17 Suppl 1():S43-8. PubMed ID: 22209930
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of an integrated primary care model on the management of middle-aged and old patients with obstructive lung diseases.
    Meulepas MA; Jacobs JE; Smeenk FW; Smeele I; Lucas AE; Bottema BJ; Grol RP
    Scand J Prim Health Care; 2007 Sep; 25(3):186-92. PubMed ID: 17846938
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Corticosteroid treatment in airways narrowing].
    Chazan R
    Pneumonol Alergol Pol; 2008; 76(2):96-100. PubMed ID: 18464224
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
    Gordon E; Lazarus SC
    J Allergy Clin Immunol; 2009 Nov; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Importance of inhaler devices in the management of airway disease.
    Virchow JC; Crompton GK; Dal Negro R; Pedersen S; Magnan A; Seidenberg J; Barnes PJ
    Respir Med; 2008 Jan; 102(1):10-9. PubMed ID: 17923402
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Current treatment of asthma and COPD has forgotten the peripheral bronchial relaxation. The small airways play a key role].
    Persson C
    Lakartidningen; 2007 Sep 12-18; 104(37):2589-90. PubMed ID: 17970393
    [No Abstract]   [Full Text] [Related]  

  • 47. The challenge of differentiating asthma from chronic obstructive pulmonary disease.
    Hanania NA
    Manag Care; 2005 Jul; 14(7 Suppl Obstructie Lung):9-15; discussion 24-6. PubMed ID: 18564559
    [No Abstract]   [Full Text] [Related]  

  • 48. Breathing space. Interview by Charlotte Alderman.
    Rushby I
    Nurs Stand; 2000 Feb 9-15; 14(21):15-6. PubMed ID: 11971298
    [No Abstract]   [Full Text] [Related]  

  • 49. Handle with care: targeting neutrophils in chronic obstructive pulmonary disease and severe asthma?
    Beeh KM; Beier J
    Clin Exp Allergy; 2006 Feb; 36(2):142-57. PubMed ID: 16433851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pharmacoeconomics of chronic obstructive pulmonary disease].
    Jahnz-Rózyk K
    Pneumonol Alergol Pol; 2009; 77(3):302-4. PubMed ID: 19591104
    [No Abstract]   [Full Text] [Related]  

  • 51. Agents against cytokine synthesis or receptors.
    Yamagata T; Ichinose M
    Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An analysis of the utilisation and expenditure of medicines dispensed for the management of severe asthma.
    McGowan B; Bennett K; Barry M; Owens M; O'Connor M
    Ir Med J; 2009 Mar; 102(3):73-6. PubMed ID: 19489193
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over.
    Tinkelman DG; Price DB; Nordyke RJ; Halbert RJ
    J Asthma; 2006; 43(1):75-80. PubMed ID: 16448970
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Resource utilization in home health chronic obstructive pulmonary disease management.
    Steinel JA; Madigan EA
    Outcomes Manag; 2003; 7(1):23-7. PubMed ID: 12593122
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monoclonal antibodies for asthma and chronic obstructive pulmonary disease.
    Antoniu SA
    Expert Opin Biol Ther; 2013 Feb; 13(2):257-68. PubMed ID: 23282002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhaler technique and training in people with chronic obstructive pulmonary disease and asthma.
    Capstick TG; Clifton IJ
    Expert Rev Respir Med; 2012 Feb; 6(1):91-101; quiz 102-3. PubMed ID: 22283582
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The revised 2014 GINA strategy report: opportunities for change.
    Boulet LP; FitzGerald JM; Reddel HK
    Curr Opin Pulm Med; 2015 Jan; 21(1):1-7. PubMed ID: 25405667
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pleiotropic effects of hypoglycemic agents: implications in asthma and COPD.
    Rogliani P; Ora J; Di Daniele N; Lauro D
    Curr Opin Pharmacol; 2018 Jun; 40():34-38. PubMed ID: 29427967
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Application of management guidelines to the assessment of new medicines: driving us forward or holding us back?
    Calverley PM; Rennard SI
    Eur Respir J; 2004 Jun; 23(6):793-4. PubMed ID: 15218985
    [No Abstract]   [Full Text] [Related]  

  • 60. Treating patients with chronic obstructive pulmonary disease.
    Hodson M; Sherrington R
    Nurs Stand; 2014 Nov; 29(9):50-8. PubMed ID: 25351094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.